Sanofi Adr Stock Today
| SNY Stock | USD 46.11 0.31 0.68% |
Performance0 of 100
| Odds Of DistressLess than 3
|
Sanofi ADR is trading at 46.11 as of the 18th of April 2024; that is 0.68 percent up since the beginning of the trading day. The stock's open price was 45.8. Sanofi ADR has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sanofi ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of April 2022 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of July 2002 | Category Healthcare | Classification Health Care |
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi-Aventis operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. The company has 2.5 B outstanding shares of which 3.9 M shares are at this time shorted by investors with about 2.34 days to cover. More on Sanofi ADR
Moving against Sanofi Stock
| 0.75 | VERA | Vera Therapeutics Downward Rally | PairCorr |
| 0.58 | VCEL | Vericel Corp Ord Financial Report 8th of May 2024 | PairCorr |
| 0.57 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
| 0.45 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
Sanofi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sanofi ADR's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sanofi ADR or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Olivier Brandicourt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | Showing 3 out of 4 themes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [SCRIPPS NTWKS-A - Dusseldorf Stock Exchang, Scripps Networks Interactive Inc] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, ARCA Pharmaceutical, NASDAQ Composite, NASDAQ Health Care, Dividend Beast, Giant Impact, Healthcare, Compulsion, Health Care, Pharmaceuticals, Drug Manufacturers—General, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Sanofi ADR report their recommendations after researching Sanofi ADR's financial statements, talking to executives and customers, or listening in on Sanofi ADR's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Sanofi ADR. The Sanofi consensus assessment is calculated by taking the average forecast from all of the analysts covering Sanofi ADR. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Sanofi ADR's profitability, liquidity, and operating efficiency, Sanofi ADR is doing better financially then in previous quarter. It has a moderate probability of reporting better financial numbers in May. Financial strength of Sanofi ADR is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sanofi ADR's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Sanofi ADR's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sanofi ADR's financial leverage. It provides some insight into what part of Sanofi ADR's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sanofi ADR (SNY) is traded on NASDAQ Exchange in USA. It is located in 46, avenue de la Grande Armée,, Paris, France, 75017 and employs 86,088 people. Sanofi ADR is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 116.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sanofi ADR's market, we take the total number of its shares issued and multiply it by Sanofi ADR's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sanofi ADR runs under Pharmaceuticals sector within Health Care industry. The entity has 2.5 B outstanding shares of which 3.9 M shares are at this time shorted by investors with about 2.34 days to cover.
Sanofi ADR has about 6.9 B in cash with 10.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76.
Check Sanofi ADR Probability Of Bankruptcy
Ownership AllocationSanofi ADR maintains a total of 2.5 Billion outstanding shares. About 90.0 % of Sanofi ADR outstanding shares are held by general public with 9.94 % by institutional holders. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Sanofi Ownership Details
Sanofi Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Sanofi ADR jumping above the current price in 90 days from now is about 90.28%. The Sanofi ADR probability density function shows the probability of Sanofi ADR stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Sanofi ADR has a beta of 0.1727. This usually implies as returns on the market go up, Sanofi ADR average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sanofi ADR will be expected to be much smaller as well. Additionally, sanofi ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Sanofi ADR to move above the current price in 90 days from now is about 90.28 (This Sanofi ADR probability density function shows the probability of Sanofi Stock to fall within a particular range of prices over 90 days) .
Sanofi Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Sanofi ADR that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sanofi ADR's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sanofi ADR's value.| Instituion | Recorded On | Shares | |
| Mondrian Investment Partners Ltd | 2023-12-31 | 2.8 M | |
| Envestnet Asset Management Inc | 2023-12-31 | 2.6 M | |
| Natixis Advisors, Llc. | 2023-12-31 | 2.5 M | |
| Hotchkis & Wiley Capital Management Llc | 2023-12-31 | 2.3 M | |
| Wells Fargo & Co | 2023-12-31 | 2.3 M | |
| Pictet Asset Manangement Sa | 2023-12-31 | 2.1 M | |
| Royal Bank Of Canada | 2023-12-31 | 2 M | |
| Equity Investment Corp | 2023-12-31 | 1.9 M | |
| Raymond James & Associates | 2023-12-31 | 1.8 M | |
| Dodge & Cox | 2023-12-31 | 78.3 M | |
| Fmr Inc | 2023-12-31 | 20.4 M |
Sanofi ADR Historical Income Statement
Sanofi ADR Income Statement is one of the three primary financial statements used for reporting Sanofi's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Sanofi ADR revenue and expense. Sanofi ADR Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Sanofi ADR's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 1.1 B in 2024, whereas Total Revenue is likely to drop slightly above 31 B in 2024. View More FundamentalsSanofi Stock Against Markets
Picking the right benchmark for Sanofi ADR stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sanofi ADR stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sanofi ADR is critical whether you are bullish or bearish towards Sanofi ADR at a given time. Please also check how Sanofi ADR's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sanofi ADR without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Sanofi ADR Corporate Directors
Sanofi ADR corporate directors refer to members of a Sanofi ADR board of directors. The board of directors generally takes responsibility for the Sanofi ADR's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Sanofi ADR's board members must vote for the resolution. The Sanofi ADR board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Emmanuel Babeau | Independent Director | Profile | |
| Fabienne Lecorvaisier | Director | Profile | |
| Klaus Pohle | Independent Director | Profile | |
| Bernard Charles | Independent Director | Profile |
How to buy Sanofi Stock?
Before investing in Sanofi ADR, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Sanofi ADR. To buy Sanofi ADR stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Sanofi ADR. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Sanofi ADR stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Sanofi ADR stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Sanofi ADR stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Sanofi ADR, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.
Already Invested in Sanofi ADR?
The danger of trading Sanofi ADR is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sanofi ADR is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sanofi ADR. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sanofi ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Sanofi Stock analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.217 | Dividend Share 3.76 | Earnings Share 2.29 | Revenue Per Share 18.388 | Quarterly Revenue Growth 0.029 |
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.